| Application no. and date | 14154762.0 (espacenet) (Federated) (European Patent Register), 20101122 | | Patent/reg. no. and date | DK/EP 2733142, 20180801 | | Publication date | 20140521 | | Priority no. and date | EP 09177371, 20091127 | | EP pub. no. and date |
EP 2733142 20140521 | | Effective date | | | Applicant/owner | Adverio Pharma GmbH, Kaiser-Wilhelm-Allee 1
51373 Leverkusen, DE | | Applicant ref. no. | Bayer BHC091038PCT-EP02 | | Inventor | REHSE, Joachim, Am Kloster 12
42799 Leichlingen, DE,
MAIS, Franz-Josef, Otto-Hahn-Str. 164
40591 Düsseldorf, DE,
Jöntgen, Winfried, SprengelstraÃYe 1
50735 Köln, DE,
Siegel, Konrad, Augsburger StraÃYe 11
40597 Düsseldorf, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 471/04 (2006.01) | | Title | Fremgangsmåde til fremstilling af methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamat til anvendelse som farmaceutisk aktivstof | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
